IIL
Innate Immuno
- Short interest
- 0.19%
- +0.11 pp 30d
- as of 27 June 2018
- Reported shorts
- 79K
- Shares on issue
- 41.023M
Innate Immuno (IIL) strategy fit
Market regime · S&P/ASX 200 (XJO)
Downtrendas of
- Close
- 8,727.9
- vs 50-day
- −1.8%
- vs 200-day
- −1.1%
- Off 52w high
- −6.1%
Downtrend: XJO is below its 200-day average.
Not evaluated yet
The picker reads a stock only with at least 60 sessions of price history in the last 400 days, and it holds fewer than that for IIL today. See what it does read on the stock picker.
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial advice